Cargando…

Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia

BACKGROUND: Cancer cachexia is a metabolic disorder characterized by the progressive loss of fat and lean mass that results in significant wasting, ultimately leading to reduced quality of life and increased mortality. Effective therapies for cachexia are lacking, potentially owing to the mismatch i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olson, Brennan, Norgard, Mason A., Levasseur, Peter R., Zhu, Xinxia, Marks, Daniel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517353/ https://www.ncbi.nlm.nih.gov/pubmed/34231343 http://dx.doi.org/10.1002/jcsm.12745

Ejemplares similares

Microglia in the hypothalamus respond to tumor‐derived factors and are protective against cachexia during pancreatic cancer
por: Burfeind, Kevin G., et al.
Publicado: (2020)

Establishment and characterization of a novel murine model of pancreatic cancer cachexia
por: Michaelis, Katherine A., et al.
Publicado: (2017)

Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
por: Olson, Brennan, et al.
Publicado: (2021)

Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer
por: Burfeind, Kevin G, et al.
Publicado: (2020)

Lipopolysaccharide‐induced hypothalamic inflammation in cancer cachexia‐anorexia is amplified by tumour‐derived prostaglandin E2
por: Li, Xiaolin, et al.
Publicado: (2022)

Neural Mechanisms of Cancer Cachexia
por: Olson, Brennan, et al.
Publicado: (2021)

Understanding Cachexia in Head and Neck Cancer
por: Muthanandam, Sivaramakrishnan, et al.
Publicado: (2021)

MyD88 signalling is critical in the development of pancreatic cancer cachexia
por: Zhu, Xinxia, et al.
Publicado: (2019)

Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia
por: Olson, Brennan, et al.
Publicado: (2020)

Characterization of a murine model of septic cachexia
por: Restagno, D, et al.
Publicado: (2014)

Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing
por: Huisman, Christian, et al.
Publicado: (2022)

Managing Cachexia in Head and Neck Cancer: a Systematic Scoping Review
por: Mäkitie, Antti A., et al.
Publicado: (2022)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi, Naomi, et al.
Publicado: (2021)

Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse
por: Aulino, Paola, et al.
Publicado: (2010)

Does perioperative oxandrolone improve nutritional status in patients with cachexia related to head and neck carcinoma?
por: Osmolak, Angela M., et al.
Publicado: (2019)

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
por: Michaelis, Katherine A., et al.
Publicado: (2019)

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
por: Michaelis, Katherine A., et al.
Publicado: (2019)

Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure
por: Scarlett, Jarrad M, et al.
Publicado: (2010)

Metastatic disease in head & neck oncology
por: Pisani, Paolo, et al.
Publicado: (2020)

Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia
por: Murphy, Kate T., et al.
Publicado: (2012)

Cancer Cachexia: Muscle Physiology and Exercise Training
por: Battaglini, Claudio L., et al.
Publicado: (2012)

Tumour-associated hypoglycaemia in a murine cachexia model.
por: McDevitt, T. M., et al.
Publicado: (1992)

Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck
por: Bhatia, Aarti, et al.
Publicado: (2017)

Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma
por: Yan, Shufang, et al.
Publicado: (2022)

Presence of cachexia in the treatment phase of head and neck cancer: a chronic nutritional condition in patients undergoing cancer therapy
por: Yasasve, Madhavan, et al.
Publicado: (2023)

Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor
por: Hussey, H J, et al.
Publicado: (2000)

Immune-relevant aspects of murine models of head and neck cancer
por: Rossa, Carlos, et al.
Publicado: (2019)

Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
por: Minohara, Kiyoshi, et al.
Publicado: (2021)

Role of radiotherapy in the treatment of metastatic head and neck cancer
por: Ordoñez, Rafael, et al.
Publicado: (2019)

Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ghosh, Soma, et al.
Publicado: (2022)

Obesity and Cachexia: Physiological Mechanisms and New Approaches to Pharmacological Control
por: Kopelman, Peter
Publicado: (1992)

Concurrent muscle and bone deterioration in a murine model of cancer cachexia
por: Choi, EunHi, et al.
Publicado: (2013)

Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model
por: Tzika, A. Aria, et al.
Publicado: (2013)

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization
por: Polo, Valentina, et al.
Publicado: (2016)

An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer
por: Wei, Tao, et al.
Publicado: (2020)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Tejani, Mohamedtaki A, et al.
Publicado: (2010)

Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab
por: Patel, Akshar N., et al.
Publicado: (2012)

Vitiligoid hypopigmentation associated with pembrolizumab in metastatic head and neck cancer
por: Bulbul, Ajaz
Publicado: (2019)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
por: Maleš, Josip, et al.
Publicado: (2021)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7emg2renle8oml3rd3r84j15mp